Once C1q recognizes antigen-bound antibody, it activates the associated proteases C1r and C1s. This creates the initiating enzymatic step that converts antibody recognition into complement processing. The sequence is important because complement activation does not begin from antibody alone; it requires antibody to be attached to antigen, linking immune surveillance to a localized response.
Activated C1r and C1s cleave C4 and C2, producing the C3 convertase C4b2a. Formation of this complex marks a transition from the recognition phase to downstream complement activity because it enables subsequent C3 cleavage. In pathway analysis, identifying C4b2a provides a mechanistic checkpoint between antibody-bound targets and later immune outcomes.
C3 cleavage distributes the pathway’s effects across three major outcomes: opsonization, inflammation, and membrane attack complex assembly. Opsonization marks pathogens for immune handling, inflammatory activity contributes to the local response, and the membrane attack complex can damage susceptible microbial membranes. Thus, C3 cleavage connects upstream recognition with several distinct defensive consequences.
Both IgM and IgG can support activation when attached to antigen, but the essential condition is antigen binding rather than antibody presence alone. This requirement directs complement toward immune complexes or antibody-coated microbial targets instead of free antibody. It also illustrates how adaptive recognition can control innate effector mechanisms during infection and immune surveillance.
Classical pathway activity is relevant beyond direct microbial damage because it is connected with immune-complex clearance. This means researchers must consider pathway function when antibody and antigen form complexes, not only when a pathogen membrane is susceptible to membrane attack complex damage. Studying both outcomes helps distinguish clearance and surveillance roles from terminal membrane injury.
Complement deficiencies provide an important context for interpreting classical-pathway function because impaired activity can affect host defense and immune-complex handling. The pathway is also relevant to inflammatory diseases, where complement activity may contribute to pathology rather than protection alone. Research therefore examines activation in relation to infection, surveillance, clearance, and inflammation.